|
|
|
25 Apr 2006 |
NeoPharm's Cintredekin Besudotox Continues to Show Evidence of Prolonged Overall Survival in Patients with Recurrent Glioblastoma Multiforme
|
|
24 Apr 2006 |
Pieris Enters Into a Collaborative Research and Option Agreement With GE Healthcare
|
|
24 Apr 2006 |
Jerini AG Completes Randomization of Last Patient in Phase III Clinical Trial (FAST 1) of Icatibant for the Treatment of Hereditary Angioedema
|
|
20 Apr 2006 |
Roche submits application to FDA to market CERA for the treatment of renal anaemia
|
|
20 Apr 2006 |
CEL-1000 Peptide Shows Adjuvant Activity with Malaria Vaccines
|
|
19 Apr 2006 |
Regeneron Completes Enrollment for IL-1 Trap Phase 3 Trial in Autoinflammatory Disease; Efficacy Phase of Trial on Target for Completion in 2006
|
|
19 Apr 2006 |
Merrimack Pharmaceuticals Completes Enrollment for Phase 2 Trial of MM-093 In Patients With Psoriasis
|
|
19 Apr 2006 |
Type 1 Diabetes Patients on Technosphere Insulin Showed HbA1c Improvements, Low Post-Prandial Glucose Fluctuations, and Weight Loss
|
|
19 Apr 2006 |
Lab International Initiates Patient Enrollment For Lab-CGRP Phase IIa Trial
|
|
19 Apr 2006 |
Sandoz Receives European Commission Marketing Authorization for Omnitrope
|
|
19 Apr 2006 |
InterMune, Inc. Completes Enrollment Of The Phase III INSPIRE Trial
|
|
18 Apr 2006 |
Chemokine Therapeutics Re-Acquires Licensing Rights to CTCE-0214 From PPD
|
|
14 Apr 2006 |
Auris Medical’s AM-111 obtains FDA orphan drug designation for the treatment of acute sensorineural hearing loss
|
|
13 Apr 2006 |
Emisphere Provides Update on Use of the eligen(R) Technology to Enhance Pulmonary Delivery of Proteins, Including Insulin
|
|
12 Apr 2006 |
Emisphere Completes Enrollment for Phase II Oral Insulin Clinical Trial
|
|
12 Apr 2006 |
Viropro Inc. acquires an exclusive licence for therapeutic proteins with Immuno Japan Inc.
|
|
11 Apr 2006 |
Affymax Begins Clinical Trial of Hematide(TM) to Treat Anemia in Patients With Pure Red Cell Aplasia
|
|
11 Apr 2006 |
Sanofi-Aventis initiates Phase II dose ranging study for the GLP-1 Agonist AVE0010 (ZP10), licensed from Zealand Pharma A/S, in Metformin-treated patients with Type 2 Diabetes
|
|
10 Apr 2006 |
Nuvelo and Bayer Healthcare Begin NAPA-3, Second Pivotal Phase 3 Trial of Alfimeprase for Acute Peripheral Arterial Occlusion
|
|
07 Apr 2006 |
FIBREX Medical: Peptide for Myocardial Infarction Proves Safe
|
|
05 Apr 2006 |
Gloucester Pharmaceuticals Reports on Preclinical Study of Depsipeptide in Pancreatic Cancer from the 97th Annual Meeting of The American Association of Cancer Research
|
|
05 Apr 2006 |
Discovery Labs Receives Second Approvable Letter from FDA
|
|
05 Apr 2006 |
Sixteen-Year Follow-up Study Reinforces Betaferon Long-Term Efficacy, Safety and Tolerability in Multiple Sclerosis
|
|
05 Apr 2006 |
Microbix enters agreement with Angiogen to commercialize a proprietary technology that uses urokinase product for treating cancer
|
|
04 Apr 2006 |
Halozyme Therapeutics Presents Preclinical and Phase I Pharmacokinetic Data for Chemophase at the 2006 American Association for Cancer Research (AACR) Annual Meeting
|
|
04 Apr 2006 |
Serono Submits New Formulation Of Rebif For Approval In The United States And In Europe
|
|
04 Apr 2006 |
Enzon Initiates Clinical Program for ONCASPAR(R); FDA Completes Review of IND
|
|
03 Apr 2006 |
Lorus announces presentation of anticancer drug platforms at the 2006 meeting of the American Association for Cancer Research (AACR)
|
|
03 Apr 2006 |
European Commission Approves Genzyme's Myozyme
|
|
01 Apr 2006 |
OncoTherapy Science, Fuso Pharmaceutical Industries Jointly Undertake Phase I Clinical Trial of Anglogenesis Inhibitor OTS102
|
|
31 Mar 2006 |
Discovery Labs Announces Preliminary Results of Phase 2 Clinical Trial in ARDS
|
|
30 Mar 2006 |
NPS Updates Status of PREOS(R) NDA
|
|
28 Mar 2006 |
Diatos Announces Expansion of Medarex Cancer Product Licensing Agreement
|
|
28 Mar 2006 |
FDA Approves Extended Dosing of Aranesp(R) to Treat Chemotherapy-Induced Anemia; Every-Three-Week Dosing Can Provide Added Convenience, Potentially Reducing Number of Clinic Visits and Injections for Anemia Treatment
|
|
28 Mar 2006 |
Allon begins dosing first patient for AL-208 Phase Ib clinical trial
|
|
25 Mar 2006 |
Once-Weekly Exenatide LAR Clinical Study in Type 2 Diabetes Initiated
|
|
25 Mar 2006 |
Paion Initiates Programme Of Next Generation Plasminogen Activators
|
|
23 Mar 2006 |
Neurobiological Technologies Inc. Announces Initiation of Second Viprinex(TM) (Ancrod) Phase III Clinical Trial for Acute Ischemic Stroke
|
|
23 Mar 2006 |
Acologix's AC-100 Stimulates Mature Bone Formation in Preclinical Study
|
|
22 Mar 2006 |
Savient and FDA Agree on Phase 3 Protocol SPA; Puricase(R) (PEG-uricase) on Track to Enter Phase 3
|
|
16 Mar 2006 |
Zealand Pharma initiates Phase 2 efficacy study in patients with acute decompensated heart failure in the US.
|
|
15 Mar 2006 |
OrthoLogic Announces Results of Phase 3 Clinical Trial of Chrysalin(R) (TP508) in Fracture Repair
|
|
14 Mar 2006 |
Human Genome Sciences Announces Positive Interim Results Of Phase 2b Clinical Trial Of Albuferon™ In Combination With Ribavirin In Treatment-Naïve Patients With Chronic Hepatitis C
|
|
14 Mar 2006 |
Human Genome Sciences Reports Positive Interim Results Of Phase 2 Trial Of Albuferon™ In Combination With Ribavirin In Treatment-Experienced Patients With Chronic Hepatitis C
|
|
14 Mar 2006 |
New Phase 2 Data Suggest Treatment of Anemia with Aranesp(R) (Darbepoetin Alfa) May Provide Clinical Benefits in Heart Failure Patients
|
|
13 Mar 2006 |
Angiomax® (bivalirudin) Monotherapy Superior to Heparins Plus GP IIb/IIIa Combination for Net Clinical Outcome in ACUITY Trial
|
|
11 Mar 2006 |
NPS Receives Approvable Letter for PREOS NDA
|
|
10 Mar 2006 |
Acologix Phase 2 Study of AC-100 (Dentonin(R)) Meets Goal of Stimulating New Dentin Formation With Favorable Safety Profile in Novel Dental Application
|
|
10 Mar 2006 |
Crucell and DSM Biologics Announce PER.C6® Licensing Agreement with UMN Pharma
|
|
09 Mar 2006 |
Kamada Receives Final FDA Approval to Commence Phase III Clinical Trials of API with Congenital Emphysema Patient
|
| |
|
Results 1301 - 1350 of 1429 |
